Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release
- PMID: 12771405
- DOI: 10.1099/vir.0.19016-0
Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release
Abstract
Modified vaccinia virus Ankara (MVA) is an attenuated strain derived from vaccinia virus (VV) Ankara that grows efficiently in primary chicken embryo fibroblasts (CEFs) and baby hamster kidney cells only. MVA produces significantly more of the enveloped forms of VV in infected CEFs compared with VV strain Copenhagen. In the present study, production of the different infectious forms of VV was compared in CEFs infected with MVA or with two well-characterized replication-competent VV strains, WR and IHD-J. In a time-course experiment, the infectivity associated with the extracellular enveloped virus (EEV), the cell-associated enveloped virus (CEV) and intracellular mature and enveloped viruses was determined. Further, the production of the different viral forms was quantified by electron microscopy (EM). The data collectively indicate that IHD-J is most efficient in producing all of the trans-Golgi network-wrapped forms and releases the highest titres of EEVs into the extracellular medium, with WR being least efficient. MVA initially replicated with faster kinetics, resulting in more intracellular virus and CEVs between 8 and 24 h post-infection (p.i.). As assessed by EM, the faster growth kinetics of MVA resulted in 3.5-fold more CEVs at the cell surface at 24 h p.i., compared with both WR and IHD-J. Accordingly, we found that despite the presence of two in-frame deletions in the A36R gene of MVA, this virus was able to make actin tails in CEFs.
Similar articles
-
Plasma membrane budding as an alternative release mechanism of the extracellular enveloped form of vaccinia virus from HeLa cells.J Virol. 2003 Sep;77(18):9931-42. doi: 10.1128/jvi.77.18.9931-9942.2003. J Virol. 2003. PMID: 12941903 Free PMC article.
-
Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.J Virol. 1992 Jul;66(7):4170-9. doi: 10.1128/JVI.66.7.4170-4179.1992. J Virol. 1992. PMID: 1602540 Free PMC article.
-
Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.J Virol. 1993 Aug;67(8):4732-41. doi: 10.1128/JVI.67.8.4732-4741.1993. J Virol. 1993. PMID: 8331727 Free PMC article.
-
The formation and function of extracellular enveloped vaccinia virus.J Gen Virol. 2002 Dec;83(Pt 12):2915-2931. doi: 10.1099/0022-1317-83-12-2915. J Gen Virol. 2002. PMID: 12466468 Review.
-
The exit of vaccinia virus from infected cells.Virus Res. 2004 Dec;106(2):189-97. doi: 10.1016/j.virusres.2004.08.015. Virus Res. 2004. PMID: 15567497 Review.
Cited by
-
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.J Virol. 2006 Jun;80(12):6033-47. doi: 10.1128/JVI.02108-05. J Virol. 2006. PMID: 16731942 Free PMC article.
-
Plasma membrane budding as an alternative release mechanism of the extracellular enveloped form of vaccinia virus from HeLa cells.J Virol. 2003 Sep;77(18):9931-42. doi: 10.1128/jvi.77.18.9931-9942.2003. J Virol. 2003. PMID: 12941903 Free PMC article.
-
A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA).Virol Sin. 2020 Apr;35(2):212-226. doi: 10.1007/s12250-019-00176-3. Epub 2019 Dec 12. Virol Sin. 2020. PMID: 31833037 Free PMC article.
-
Infectio: a Generic Framework for Computational Simulation of Virus Transmission between Cells.mSphere. 2016 Feb 10;1(1):e00078-15. doi: 10.1128/mSphere.00078-15. eCollection 2016 Jan-Feb. mSphere. 2016. PMID: 27303704 Free PMC article.
-
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.Appl Microbiol Biotechnol. 2019 Apr;103(7):3025-3035. doi: 10.1007/s00253-019-09694-2. Epub 2019 Feb 23. Appl Microbiol Biotechnol. 2019. PMID: 30796494 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials